Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Stanford University lays off over 360 employees, citing Trump policies
-
ATA Creativity Global signs MOU for up to $100 million investment deal
-
Record 116 nominees named to 2025 Allstate Wuerffel Trophy Watch List, College Football’s Premier Award for Community Service
-
ADP Employment Change (Jul) 104K vs 76 Expected
-
Siegel Family Endowment Awards Nearly $17 Million in Grants to Advance Future-Ready Learning, Workforce Development, and Community-Centered Innovation
-
Rafe Furst rejoins The Crypto Company as chief strategy officer
-
Citizens JMP Reiterates Market Outperform Rating on salesforce.com (CRM)
-
George Malkin joins Empire State Realty Trust board of directors
-
Cummins elects Matthew Tsien to board of directors
-
Resolute Holdings appoints two independent directors to board
-
Form 3 Strawberry Fields REIT, For: Jul 09 Filed by: Gertz Stanford
-
Salesforce adds Amy Chang and David Kirk to board of directors
-
First Trust Fund AlphaDEX (FXO) becomes second largest Freedom Holding (FRHC) shareholder
-
Nuvve Holding (NVVE) names Laura Huang and Brian Johnson to Board
-
Northwest Natural Gas (NWN) Announce New Board Members
-
ADP Employment Change (Jun) -33K vs 98K Expected
-
BigCommerce (BIGC) Appoints Anil Kamath to its Board
-
New Era Helium (NEHC) Strengthens Board
-
Longeveron (LGVN) Appoints Than Powell as Chief Business Officer
-
Six Flags (FUN): Shareholders Elect Four Independent Directors to Board
-
CalciMedica (CALC) Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure
-
Netflix (NFLX): Ellie Mertz Appointed to Board of Directors
-
AMN Healthcare Services Inc (AMN) Appoints Celia Huber to its Board
-
Safe and Green Development (SGD) Appoints Bjarne Borg, James D. Burnham, and Anthony M. Cialone to its Board
-
Dot Ai Completes Business Combination; Will Begin Trading on Nasdaq Stock Market (DAIC)
-
Marti Technologies (MRT) Appoints Cankut Durgun as COO
-
Stanford Founder Launches World's First Universal Fashion AI Agent to Transform $7.7 Trillion Industry
-
Aptose (APS) announces data from TUSCANY trial evaluating tuspetinib
-
Stanford Health Care and Kivo Health Collaborate to Advance Value Based Care for COPD through Virtual Pulmonary Rehabilitation
-
Relay Therapeutics (RLAY) appoints Claire Mazumdar to Board
-
Hyperfine (HYPR) Announces Executive Appointments
-
Nano Dimension (NNDM) Strengthens Board with Technology and Growth Experts
-
Franklin Covey (FC) Appoints Dariusz Paczuski as Chief Marketing Officer
-
Roblox (RBLX) Appoints Naveen Chopra as Chief Financial Officer
-
OPKO Health's (OPK) ModeX Therapeutics Forms Scientific Advisory Board
-
Fox Corporation (FOX) names Puja Vohra as CMO and EVP
-
Trump urges Fed Chair Powell to cut rates after ADP jobs data release
-
ADP Employment Change (May) 37K vs 114K Expected
-
Vera Therapeutics Inc. (VERA) Reports Atacicept Achieved 46% Proteinuria Reduction in ORIGIN Phase 3 Trial
-
TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI
-
Revelation Biosciences (REVB) announces Board retirement
-
Essent Group (ESNT) Announces 2 New Directors of the Board
-
MercadoLibre (MELI) CEO transitions to Executive Chairman
-
VSee Health (VSEE) launches Project MAMA, AI-powered telehealth initiative
-
Luminar Technologies (LAZR) appoints Paul Ricci as new CEO
-
Form 4 GLEN BURNIE BANCORP For: Jun 14 Filed by: Hess Stanford
-
Knight-Hennessy Scholars announces 2025 cohort of new scholars
-
Cisco Systems (CSCO) Appoints Kevin Weil to its Board
-
Stanford Department of Health Policy: When Healthcare Providers Go Bankrupt, Patients Pay the Price
-
Corvus Pharma (CRVS) Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

